| Product Code: ETC6657375 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Canada Gastric Cancer Market Overview |
3.1 Canada Country Macro Economic Indicators |
3.2 Canada Gastric Cancer Market Revenues & Volume, 2021 & 2031F |
3.3 Canada Gastric Cancer Market - Industry Life Cycle |
3.4 Canada Gastric Cancer Market - Porter's Five Forces |
3.5 Canada Gastric Cancer Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Canada Gastric Cancer Market Revenues & Volume Share, By Stages, 2021 & 2031F |
3.7 Canada Gastric Cancer Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.8 Canada Gastric Cancer Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.9 Canada Gastric Cancer Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.10 Canada Gastric Cancer Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.11 Canada Gastric Cancer Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Canada Gastric Cancer Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of gastric cancer in Canada |
4.2.2 Technological advancements in diagnostic and treatment options |
4.2.3 Growing awareness and screening programs for early detection |
4.2.4 Rising healthcare expenditure and government initiatives for cancer care |
4.3 Market Restraints |
4.3.1 High cost of cancer treatments and medications |
4.3.2 Limited access to specialized healthcare facilities in certain regions of Canada |
4.3.3 Potential side effects and risks associated with cancer treatments |
4.3.4 Regulatory challenges and lengthy approval processes for new therapies |
5 Canada Gastric Cancer Market Trends |
6 Canada Gastric Cancer Market, By Types |
6.1 Canada Gastric Cancer Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Canada Gastric Cancer Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Canada Gastric Cancer Market Revenues & Volume, By Adenocarcinoma, 2021- 2031F |
6.1.4 Canada Gastric Cancer Market Revenues & Volume, By Lymphoma, 2021- 2031F |
6.1.5 Canada Gastric Cancer Market Revenues & Volume, By Gastrointestinal Stromal Tumor, 2021- 2031F |
6.1.6 Canada Gastric Cancer Market Revenues & Volume, By Carcinoid Tumor, 2021- 2031F |
6.1.7 Canada Gastric Cancer Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Canada Gastric Cancer Market, By Stages |
6.2.1 Overview and Analysis |
6.2.2 Canada Gastric Cancer Market Revenues & Volume, By Stage I, 2021- 2031F |
6.2.3 Canada Gastric Cancer Market Revenues & Volume, By Stage II, 2021- 2031F |
6.2.4 Canada Gastric Cancer Market Revenues & Volume, By Stage III, 2021- 2031F |
6.2.5 Canada Gastric Cancer Market Revenues & Volume, By Stage IV, 2021- 2031F |
6.2.6 Canada Gastric Cancer Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Canada Gastric Cancer Market, By Diagnosis |
6.3.1 Overview and Analysis |
6.3.2 Canada Gastric Cancer Market Revenues & Volume, By Endoscopy, 2021- 2031F |
6.3.3 Canada Gastric Cancer Market Revenues & Volume, By Biopsy, 2021- 2031F |
6.3.4 Canada Gastric Cancer Market Revenues & Volume, By Imaging Tests, 2021- 2031F |
6.3.5 Canada Gastric Cancer Market Revenues & Volume, By Exploratory Surgery, 2021- 2031F |
6.3.6 Canada Gastric Cancer Market Revenues & Volume, By Other, 2021- 2031F |
6.4 Canada Gastric Cancer Market, By Treatment |
6.4.1 Overview and Analysis |
6.4.2 Canada Gastric Cancer Market Revenues & Volume, By Surgery, 2021- 2031F |
6.4.3 Canada Gastric Cancer Market Revenues & Volume, By Radiation Therapy, 2021- 2031F |
6.4.4 Canada Gastric Cancer Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.4.5 Canada Gastric Cancer Market Revenues & Volume, By Targeted Therapy, 2021- 2031F |
6.4.6 Canada Gastric Cancer Market Revenues & Volume, By Palliative Care, 2021- 2031F |
6.4.7 Canada Gastric Cancer Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Canada Gastric Cancer Market, By Route of Administration |
6.5.1 Overview and Analysis |
6.5.2 Canada Gastric Cancer Market Revenues & Volume, By Oral, 2021- 2031F |
6.5.3 Canada Gastric Cancer Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.5.4 Canada Gastric Cancer Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Canada Gastric Cancer Market, By End-Users |
6.6.1 Overview and Analysis |
6.6.2 Canada Gastric Cancer Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 Canada Gastric Cancer Market Revenues & Volume, By Homecare, 2021- 2031F |
6.6.4 Canada Gastric Cancer Market Revenues & Volume, By Speciality Centres, 2021- 2031F |
6.6.5 Canada Gastric Cancer Market Revenues & Volume, By Others, 2021- 2031F |
6.7 Canada Gastric Cancer Market, By Distribution Channel |
6.7.1 Overview and Analysis |
6.7.2 Canada Gastric Cancer Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.7.3 Canada Gastric Cancer Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.7.4 Canada Gastric Cancer Market Revenues & Volume, By , 2021- 2031F |
7 Canada Gastric Cancer Market Import-Export Trade Statistics |
7.1 Canada Gastric Cancer Market Export to Major Countries |
7.2 Canada Gastric Cancer Market Imports from Major Countries |
8 Canada Gastric Cancer Market Key Performance Indicators |
8.1 Survival rates of patients diagnosed with gastric cancer |
8.2 Adoption rate of new diagnostic technologies and treatment methods |
8.3 Number of healthcare facilities offering specialized care for gastric cancer |
8.4 Participation rates in cancer screening and prevention programs |
8.5 Patient satisfaction with the quality of care and support received |
9 Canada Gastric Cancer Market - Opportunity Assessment |
9.1 Canada Gastric Cancer Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Canada Gastric Cancer Market Opportunity Assessment, By Stages, 2021 & 2031F |
9.3 Canada Gastric Cancer Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.4 Canada Gastric Cancer Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.5 Canada Gastric Cancer Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.6 Canada Gastric Cancer Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.7 Canada Gastric Cancer Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Canada Gastric Cancer Market - Competitive Landscape |
10.1 Canada Gastric Cancer Market Revenue Share, By Companies, 2024 |
10.2 Canada Gastric Cancer Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |